Clinically stable treatment-experienced adults receiving tenofovir and didanosine.

@article{Biagio2006ClinicallyST,
  title={Clinically stable treatment-experienced adults receiving tenofovir and didanosine.},
  author={Antonio Di Biagio and Andrea Beltrame and Giovanni Cenderello and Giuseppe Ferrea and Andrea de Maria},
  journal={HIV clinical trials},
  year={2006},
  volume={7 1},
  pages={
          10-5
        }
}
METHOD Analysis of virological, immunological, and clinical data over 24 weeks of treatment of drug-experienced patients administered didanosine (ddI) and tenofovir (TDF) plus either PI or NNRTI (17 patients) compared to 14 patients on ddI plus lamivudine and to 19 patients on ddI plus stavudine. RESULTS Patients treated with TDF and ddI do not have a higher risk of early immunological or virological failure. CONCLUSION Treatment success and increase in CD4+ lymphocytes may depend, among… CONTINUE READING
BETA